Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Solid Tumor Cancer × Pemetrexed × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 23 Lung Neoplasms 4 Small Cell Lung Carcinoma 2 Uterine Cervical Neoplasms 1 Stereotactic Radiotherapy; Evoximab (AK112); New Adjuvant Therapy for Non-small Cell Lung Cancer 1 Solid Tumors 1 Solid Tumor Cancer 1 Pathologic Complete Response 1 Non-squamous Non-small Cell Lung Cancer 1 Non-small Cell Lung Cancer Metastatic 1 Non Squamous Non-small Cell Lung Cancer 1 Neoplasms 1 Neoplasm Metastasis 1 NSCLC 1 Mesothelioma, Malignant 1 Meningeal Carcinomatosis 1 Lung Diseases, Interstitial 1 Disease Progression 1 Brain Neoplasms 1 Advanced Solid Tumor 1

Interventions

irinotecan sucrosofate 1 Vincristine 1 Temozolomide 1 TP protocol 1 Pemetrexed 1 Paclitaxel 1 PE regimen 1 Immunotherapy 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06649448 2024-10-18

EF-001

Shandong Cancer Hospital and Institute

Phase NA Not yet recruiting

Other solid neoplasm

Solid Tumor Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡